Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Servier Hellas Pharmaceuticals Ltd.
This is a non-interventional study aiming to record adherence to treatment with Perindopril/Indapamide/Amlodipine fixed dose combination. In parallel blood pressure levels will be recorded, as well as safety and tolerability of this fixed dose combination.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male or female, ambulatory patients \>18 years old.
Under treatment with Perindoril/Indapamide/Amlodipine fixed dose combination.
The patient has given his/her written consent after being informed, before his inclusion in the study.
You may not be if
Secondary arterial hypertension.
Serious end stage diseases, severe neuropsychiatric diseases, cerebrovascular event with serious residual lesions, scheduled procedure or surgical operation or hospital admission.
Pregnancy, lactation or intention to become pregnant.
Clareo Health | Study for the Recording of Adherence to Treatment With Perindopril/Indapamide/Amlodipine Fixed Dose Combination
